Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Canopy Growth can move ahead with its plans to acquire U.S.-based cannabis companies via Canopy USA. The company, however, won't be able to consolidate the results.

Canopy Growth Obtains Shareholder Approval to Move Ahead With Canopy USA: Here's What It Means for Investors

Aurora Cannabis

The global cannabis industry and top marijuana stocks are poised for significant growth, driven by increasing legalization and medical use. Furthermore, experts predict a compound annual growth rate of over 20% for the next decade. Consequently, this expansion benefits top Canadian companies such as Canopy Growth, Aurora Cannabis, and Aphria. These firms lead the market in innovation and distribution. Therefore, investors should closely monitor these names, as they could capitalize on global trends.

Top Canadian Cannabis Contenders: Stocks to Watch Before May 2024

Trump Media & Technology Group Corp

GameStop

Nordstrom

Paramount Global

Tilray Brands

Express

If you're wondering what stocks to sell this quarter, you're in the right place. Nothing lasts forever, not even stocks.

7 Stocks That Could Be Heading Six-Feet Under

Cronos Group

The cannabis industry has rapidly become a significant sector within the stock market, attracting a diverse array of investors. Yet marijuana stocks are notorious for their volatility, influenced heavily by regulatory changes and political dynamics. This article explores essential strategies for investing in cannabis stocks during these fluctuating conditions. Plus highlights how political developments can impact the way most marijuana stocks trade. Navigating the marijuana stock market requires savvy investment strategies that account for its inherent unpredictability.

Top Canadian Marijuana Stocks To Invest In For Big Gains

Marijuana legalization may be inching closer in the U.S. but it just became a reality in Germany. As of April 1, Germans can now legally grow up to three marijuana plants for personal use.

Cashing in on Cannabis: Why These 3 Weed Stocks Are Primed to Pop

Beyond Meat

QuantumScape

As concerns about a global recession grow, it might be wise to consider divesting from certain Nasdaq stocks to sell. The Nasdaq is known for hosting a range of innovative tech companies.

3 Nasdaq Stocks That Could Be Heading Six-Feet Under

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

Cannabis culture is being celebrated today on “4/20” with weed lovers gathering at events to partake in the plant and enjoy retail promotions.   While the history of 4/20 is disputed, most trace it back to a group of students who attended San Rafael High School in California in the 1970s.

4/20 2024: Cannabis investors have much to celebrate this year

Innovative Industrial Properties

IM Cannabis Corp

The progress toward legalization of cannabis in the United States continues at a slow pace, but medical marijuana is now permitted in approximately 37 states. Germany recently became the latest country to legalize cannabis for personal use beginning in April, coinciding with the informal holiday of 4/20.

Puff, Puff, Invest: 3 Top Cannabis Stock Picks to Celebrate 4/20

Constellation Brands

Alcoholic-beverage giant Constellation Brands Inc. on Thursday announced a number of moves intended to further distance itself from struggling Canadian cannabis producer Canopy Growth Corp., following a multibillion-dollar investment in the pot company several years ago.

Constellation Brands moves itself further away from cannabis grower Canopy Growth's business

Conversion of Greenstar Promissory Note into Exchangeable Shares further improves Canopy's balance sheet through the elimination of short term debt, reduces overall debt balance by C$100MM SMITHS FALLS, ON , April 18, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) announced today that in connection with the creation of the non-voting and non-participating exchangeable shares in the capital of Canopy Growth (the "Exchangeable Shares"), on April 18, 2024, Greenstar Canada Investment Limited Partnership ("Greenstar") and CBG Holdings LLC ("CBG" and, together with Greenstar, the "CBG Group"), each a wholly-owned subsidiary of Constellation Brands, Inc. ("CBI"), exchanged all 17,149,925 common shares in the capital of the Company (the "Common Shares") they collectively held for 17,149,925 Exchangeable Shares (the "CBI Exchange") for no consideration. As a result of the CBI Exchange, the CBG Group no longer holds any Common Shares.

Canopy Growth Announces CBI Conversion to Exchangeable Shares and Newly Constituted Board of Directors

Among the unlikely winners that are once again seeing strong interest in today's market, Canopy Growth (NASDAQ: CGC ) is on a tear. Shares of CGC stock are up a whopping 25% in early afternoon trading, prompting questions of whether this stock is due for a short squeeze.

Is a Short Squeeze Brewing in Canopy Growth (CGC) Stock?

Canopy Growth Corporation (TSX:WEED, NYSE:CGC) shares are trending upwards after the Ontario-based company's shareholders approved a new class of shares that will enable its swift expansion into the US cannabis market. At a special shareholder meeting on Friday, April 12, investors approved a new exchangeable share structure that will facilitate its operations in the US under a US-domiciled holding company Canopy USA.

Canopy Growth shares surge as shareholder vote paves way for expansion into US market

The National Conference of State Legislatures is urging Congress to pass its Secure and Fair Enforcement Regulation (SAFER) Banking Act. Passage of SAFER would permit banks to offer ordinary banking services to legal marijuana businesses -- services they lack access to today.

Why Canopy Growth Stock Is Glowing Green Today

Cannabis stocks to buy now could see higher highs, as we near the U.S. elections.  For one, a growing number of Americans want to see legalization.

The 3 Best Cannabis Stocks to Buy Now: Q2 Edition

Tilray Brands and Canopy Growth are often the default options for investors looking for cannabis stocks. But those are risky, cash-burning businesses counting on the hopes that the U.S. legalizes marijuana soon.

The Best Cannabis Stock to Invest $1,000 in Right Now

AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure Cannabis ETF 

With April 20 approaching (a notable cannabis celebration indeed), thoughts may turn to investing in marijuana stocks. However, beyond the symbolic date, imminent catalysts could drive significant growth in this sector for speculators and those wishing well on the providers of sticky icky turning higher.

High Hopes: Could 4/20 Light Up a Cannabis Stock Rally?

As we move into mid-April 2024, Canadian marijuana stocks are capturing the attention of investors, given the ongoing developments and shifts in the global cannabis market. Stocks like Tilray, Canopy Growth, and Aurora Cannabis are notable for their robust international operations and diverse product lines. Tilray, for example, has expanded its presence in the U.S. through acquisitions like MedMan, positioning it well to capitalize on potential market expansions. Canopy Growth has made significant strides in operational efficiency, achieving considerable cost savings and enhancing its financial health, which speaks to its ability to navigate a complex market landscape.

April 2024's Hot Picks: Top Canadian Cannabis Stocks To Watch Now

Despite a seemingly positive move forward, Canopy Growth (NASDAQ: CGC ) shares are experiencing significant volatility today. Part of that may stem from dilution risks tied to its business decision, which involves creating a separate U.S.-focused enterprise.

CGC Stock Alert: Canopy Growth Gets Green Light for Canopy USA

Canopy Growth shrank significantly over the last few years. Management has its fingers crossed for marijuana legalization in the U.S. Even that might not be enough to make it an appealing investment.

Canopy Growth: Buy, Sell, or Hold?

Shareholders overwhelmingly approve the creation of a new class of Exchangeable Shares of Canopy Growth, enabling the acceleration of Canopy Growth's entry into the U.S. THC market, which is expected to be approximately $50B in 2026.1 Canopy USA expected to advance imminently with triggering acquisition of U.S. assets. SMITHS FALLS, ON, April 15, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announced the voting results from its special meeting of shareholders held on Friday, April 12, 2024 (the "Meeting").

CANOPY GROWTH ANNOUNCES RESULTS OF SPECIAL MEETING OF SHAREHOLDERS

Despite a volatile week for cannabis specialist Canopy Growth (NASDAQ: CGC ), CGC stock has enjoyed a tremendous performance over the past month, gaining about 163%. Currently, shareholders are voting on two proposals related to the creation of a U.S.-based entity called Canopy USA.

CGC Stock Is on Watch Amid ‘Canopy USA' Vote

Village Farms International

Marijuana stock investors are seeing the future of cannabis and investing transforming. What does this mean exactly? So from earlier on in the green rush most marijuana stocks traded as if they were never coming down. The excitement of publicly traded cannabis companies being traded on the open market was incredible. Even when slight drops would occur they were often followed by strong recoveries. Now this was back in 2018, and 2019.

These Marijuana Stocks Could Begin To Rise Again?

Canopy Growth is eager to enter the U.S. cannabis market. If legalization takes place within the next decade, it could be off to the races for the cannabis producer.

Where Will Canopy Growth Be in 10 Years?

Tilray reported weaker-than-expected sales growth and a big GAAP loss this morning. Competing marijuana stocks are suffering, too.

Why Marijuana Stocks Got Burnt Today

It has been a great month for Canopy Growth (NASDAQ: CGC ), as shares of CGC stock are up by more than 230%. These gains have been led by a combination of several factors, such as comments from President Joe Biden and Vice President Kamala Harris about reclassifying marijuana from a Schedule 1 drug, the legalization of marijuana in Germany and a November vote to legalize recreational marijuana in Florida.

News for Canopy Growth Stock (CGC)